Sector Gamma AS increased its position in shares of Bruker Co. (NASDAQ:BRKR) by 38.1% during the third quarter, Holdings Channel reports. The fund owned 308,004 shares of the medical research company’s stock after acquiring an additional 85,000 shares during the quarter. Bruker makes up 2.3% of Sector Gamma AS’s holdings, making the stock its 17th largest holding. Sector Gamma AS’s holdings in Bruker were worth $13,531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Advisory Services Network LLC acquired a new position in Bruker in the 2nd quarter valued at approximately $89,000. NumerixS Investment Technologies Inc increased its stake in Bruker by 153.2% in the 2nd quarter. NumerixS Investment Technologies Inc now owns 2,532 shares of the medical research company’s stock valued at $126,000 after buying an additional 1,532 shares during the period. Machina Capital S.A.S. acquired a new position in Bruker in the 2nd quarter valued at approximately $132,000. New York State Teachers Retirement System acquired a new position in Bruker in the 2nd quarter valued at approximately $150,000. Finally, HWG Holdings LP acquired a new position in Bruker in the 2nd quarter valued at approximately $172,000. Institutional investors and hedge funds own 66.46% of the company’s stock.
In other news, CEO Burkhard Prause sold 15,702 shares of the stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $42.96, for a total value of $674,557.92. Following the completion of the transaction, the chief executive officer now owns 1,338 shares in the company, valued at approximately $57,480.48. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Mark Munch sold 47,203 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $42.87, for a total transaction of $2,023,592.61. Following the completion of the transaction, the vice president now owns 96,063 shares of the company’s stock, valued at approximately $4,118,220.81. The disclosure for this sale can be found here. In the last 90 days, insiders sold 66,108 shares of company stock valued at $2,849,941. Corporate insiders own 26.50% of the company’s stock.
Several research analysts have weighed in on the stock. Bank of America upgraded shares of Bruker from a “neutral” rating to a “buy” rating and set a $52.00 price objective on the stock in a research note on Thursday, September 26th. Zacks Investment Research lowered shares of Bruker from a “hold” rating to a “sell” rating and set a $46.00 price objective on the stock. in a research note on Tuesday, October 15th. Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and upped their price objective for the company from $32.00 to $48.00 in a research note on Monday, July 15th. Needham & Company LLC set a $58.00 price objective on shares of Bruker and gave the company a “buy” rating in a research note on Friday, September 27th. Finally, BidaskClub lowered shares of Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, August 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $50.70.
Shares of BRKR traded up $0.80 during mid-day trading on Friday, hitting $47.90. 511,900 shares of the company’s stock were exchanged, compared to its average volume of 752,409. The company has a quick ratio of 1.27, a current ratio of 2.23 and a debt-to-equity ratio of 0.67. Bruker Co. has a twelve month low of $26.10 and a twelve month high of $52.23. The firm has a fifty day moving average of $44.58 and a two-hundred day moving average of $44.26. The stock has a market cap of $7.33 billion, a price-to-earnings ratio of 34.21, a P/E/G ratio of 2.34 and a beta of 1.36.
Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, October 31st. The medical research company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.05. Bruker had a net margin of 10.20% and a return on equity of 28.02%. The firm had revenue of $521.10 million during the quarter, compared to the consensus estimate of $493.52 million. During the same period in the prior year, the firm earned $0.37 EPS. The business’s revenue was up 11.7% on a year-over-year basis. On average, equities analysts predict that Bruker Co. will post 1.62 earnings per share for the current year.
Bruker Company Profile
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Further Reading: What is Call Option Volume?
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.